5HI5

Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
  • R-Value Free: 0.219 
  • R-Value Work: 0.201 
  • R-Value Observed: 0.202 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists.

Liu, S.Dakin, L.A.Xing, L.Withka, J.M.Sahasrabudhe, P.V.Li, W.Banker, M.E.Balbo, P.Shanker, S.Chrunyk, B.A.Guo, Z.Chen, J.M.Young, J.A.Bai, G.Starr, J.T.Wright, S.W.Bussenius, J.Tan, S.Gopalsamy, A.Lefker, B.A.Vincent, F.Jones, L.H.Xu, H.Hoth, L.R.Geoghegan, K.F.Qiu, X.Bunnage, M.E.Thorarensen, A.

(2016) Sci Rep 6: 30859-30859

  • DOI: 10.1038/srep30859
  • Structures With Same Primary Citation

  • PubMed Abstract: 
  • Interleukin-17A (IL-17A) is a principal driver of multiple inflammatory and immune disorders. Antibodies that neutralize IL-17A or its receptor (IL-17RA) deliver efficacy in autoimmune diseases, but no small-molecule IL-17A antagonists have yet progr ...

    Interleukin-17A (IL-17A) is a principal driver of multiple inflammatory and immune disorders. Antibodies that neutralize IL-17A or its receptor (IL-17RA) deliver efficacy in autoimmune diseases, but no small-molecule IL-17A antagonists have yet progressed into clinical trials. Investigation of a series of linear peptide ligands to IL-17A and characterization of their binding site has enabled the design of novel macrocyclic ligands that are themselves potent IL-17A antagonists.


    Organizational Affiliation

    Worldwide Medicinal Chemistry, Pfizer Worldwide R&D, 610 Main Street, Cambridge, MA 02139, USA.



Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Interleukin-17AA, B132Homo sapiensMutation(s): 0 
Gene Names: IL17ACTLA8IL17
Find proteins for Q16552 (Homo sapiens)
Explore Q16552 
Go to UniProtKB:  Q16552
NIH Common Fund Data Resources
PHAROS  Q16552
Protein Feature View
 ( Mouse scroll to zoom / Hold left click to move )
  • Reference Sequence

Find similar proteins by: Sequence  |  Structure

Entity ID: 3
MoleculeChainsSequence LengthOrganismDetails
CAT-2000 light chainD, L214Homo sapiensMutation(s): 0 
Protein Feature View
 ( Mouse scroll to zoom / Hold left click to move )
  • Reference Sequence
  • Find similar proteins by: Sequence   |   Structure
Entity ID: 4
MoleculeChainsSequence LengthOrganismDetails
synthetic IL-17A inhibitorI16synthetic constructMutation(s): 0 
Protein Feature View
 ( Mouse scroll to zoom / Hold left click to move )
  • Reference Sequence

Find similar proteins by: Sequence  |  Structure

Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
CAT-2000 FAB heavy chainC, H237Homo sapiensMutation(s): 0 
Protein Feature View
 ( Mouse scroll to zoom / Hold left click to move )
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
63Q
Query on 63Q

Download CCD File 
B
(4S,20R)-7-chloro-N-methyl-4-{[(1-methyl-1H-pyrazol-5-yl)carbonyl]amino}-3,18-dioxo-2,19-diazatetracyclo[20.2.2.1~6,10~.1~11,15~]octacosa-1(24),6(28),7,9,11(27),12,14,22,25-nonaene-20-carboxamide
C33 H33 Cl N6 O4
CEFRORFLEYHRHI-IZLXSDGUSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
63QIC50:  9   nM  Binding MOAD
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
  • R-Value Free: 0.219 
  • R-Value Work: 0.201 
  • R-Value Observed: 0.202 
  • Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 91.32α = 90
b = 68.68β = 90.65
c = 100.53γ = 90
Software Package:
Software NamePurpose
BUSTERrefinement
AutoPROCdata scaling
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

  • Deposited Date: 2016-01-11 
  • Released Date: 2016-08-31 
  • Deposition Author(s): Liu, S.

Revision History 

  • Version 1.0: 2016-08-31
    Type: Initial release
  • Version 1.1: 2017-11-22
    Changes: Derived calculations, Refinement description